點(diǎn)擊試劑:反式環(huán)辛烯-琥珀酰亞胺酯,CAS:1191901-33-3
產(chǎn)品信息:
英文名稱:TCO-NHS Ester,Trans-Cyclooctene-NHS ester
中文名稱: 反式環(huán)辛烯-活性脂,反式環(huán)辛烯-琥珀酰亞胺酯
CAS:1191901-33-3
分子式:C13H17NO5
分子量:267.28
溶解性:DMSO, DMF, DCM, THF, Chloroform
純度:>95% (HPLC)
結(jié)構(gòu)式:
廠 家:陜西新研博美生物科技有限公司
請(qǐng)點(diǎn)擊此處進(jìn)入陜西新研博美生物科技有限公司展臺(tái)查看
請(qǐng)點(diǎn)擊此處進(jìn)入陜西新研博美生物科技有限公司展臺(tái)查看
產(chǎn)品簡(jiǎn)介:
TCO-NHS Ester is an amine-reactive building block used for modification of amine-containing molecule in organic media. TCO-NHS ester is supplied as a single axial (major) diastereomer. Specially formulated crystalline provides easy handling and extended shelf life.
Important Product Information:
TCO-NHS Ester is not recommended for labelling of proteins in aqueous buffers due to poor level of activation of labelled proteins (Rahim, M.K., et al., Bioconjugate Chem. 2015, 26, 352-360). TCO-PEG4-NHS Ester and TCO-PEG12-NHS Ester are well suited for protein and antibody labelling in aqueous buffers.
TCO-Tetrazine Ligation Chemistry產(chǎn)品列表:
Trans-Cyclooctene (TCO)-Amine
Trans-Cyclooctene (TCO)-NHS Ester
Trans-Cyclooctene (TCO)-PEG3-Maleimide
Trans-Cyclooctene (TCO)-PEG4-NHS Ester
TCO-PEG4-NHS ester
UV-Tracer TCO-NHS ester
TCO-NHS ester
TCO-Amine
TCO-PEG3-Maleimide
TCO-Amine HCl salt
TCO-PEG12-DBCO
Tetrazine-Amine
Tetrazine-NHS
Tetrazine-DBCO
Tetrazine-PEG5-NHS ester
Tetrazine-PEG4-Maleimide
Tetrazine-PEG4-Alkyne
Tetrazine-PEG4-Azide
Cy3-Tetrazine
Cy5-TCO
Cy5-Tetrazine
Methyltetrazine-PEG4-Maleimide
反式環(huán)辛烯-活性脂;TCO NHS;1191901-33-3
相關(guān)產(chǎn)品
免責(zé)聲明
- 凡本網(wǎng)注明“來(lái)源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來(lái)源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來(lái)源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)和對(duì)其真實(shí)性負(fù)責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品第一來(lái)源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問(wèn)題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。